Tokyo Tape
Sign in
← CellSeed

Quarterly report · Q2

7776.TEDINET S100RMQI
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥67m2023-01-01 → 2023-06-30StandaloneNet sales
Revenue¥126m2022-01-01 → 2022-12-31StandaloneNet sales (5-year summary)
Revenue¥75m2022-01-01 → 2022-06-30StandaloneNet sales
Operating income−¥359m2023-01-01 → 2023-06-30StandaloneOperating income
Operating income−¥349m2022-01-01 → 2022-06-30StandaloneOperating income
Ordinary income−¥367m2023-01-01 → 2023-06-30StandaloneOrdinary income
Ordinary income−¥754m2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥353m2022-01-01 → 2022-06-30StandaloneOrdinary income
Profit before tax−¥363m2023-01-01 → 2023-06-30StandaloneIncome before income taxes
Profit before tax−¥355m2022-01-01 → 2022-06-30StandaloneIncome before income taxes
Net income−¥364m2023-01-01 → 2023-06-30StandaloneProfit loss
Net income−¥760m2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Net income−¥357m2022-01-01 → 2022-06-30StandaloneProfit loss
Total assets¥2.0bnat 2023-06-30StandaloneAssets
Total assets¥1.5bnat 2022-12-31StandaloneAssets
Total assets¥1.7bnat 2022-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥363mat 2023-06-30StandaloneLiabilities
Total liabilities¥366mat 2022-12-31StandaloneLiabilities
Net assets / equity¥1.7bnat 2023-06-30StandaloneNet assets
Net assets / equity¥1.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.3bnat 2022-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.6bnat 2023-06-30StandaloneCash and deposits
Cash and deposits¥1.1bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥1.6bnat 2023-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.2bnat 2022-06-30StandaloneCash and cash equivalents
Cash & equivalents¥847mat 2021-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥348m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥718m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥269m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow¥18m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥62m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥15m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥848m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥882m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥606m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-13.292023-01-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.492023-04-01 → 2023-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.312022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-18.542022-01-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-7.752022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio81.1%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio74.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio75.1%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued28,385,419at 2023-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued24,422,619at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued22,159,419at 2022-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥96m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2023-01-01 → 2023-06-30¥5m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2023-01-01 → 2023-06-30¥5m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2023-01-01 → 2023-06-30−¥236m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2023-01-01 → 2023-06-30¥62m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2023-01-01 → 2023-06-30¥62m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2023-01-01 → 2023-06-30−¥28m
—segment totalrevenue2023-01-01 → 2023-06-30¥67m
—segment totalrevenue external2023-01-01 → 2023-06-30¥67m
—segment totalsegment profit2023-01-01 → 2023-06-30−¥263m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥100m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2022-01-01 → 2022-06-30¥4m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2022-01-01 → 2022-06-30¥4m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2022-01-01 → 2022-06-30−¥208m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2022-01-01 → 2022-06-30¥70m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2022-01-01 → 2022-06-30¥70m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2022-01-01 → 2022-06-30−¥41m
—segment totalrevenue2022-01-01 → 2022-06-30¥75m
—segment totalrevenue external2022-01-01 → 2022-06-30¥75m
—segment totalsegment profit2022-01-01 → 2022-06-30−¥248m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 443
ItemContextValueUnit
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember1645892000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember-321000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember11922000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember-321000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember11922000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember24232000JPY
Subscription rights to sharesCurrentQuarterInstant_NonConsolidatedMember24589000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1178338000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember1682404000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember1543920000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember2045042000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember74612000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember66966000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember38570000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember28546000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember36041000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember38419000JPY
Research and development expenses sgaPrior1YTDDuration_NonConsolidatedMember200501000JPY
Research and development expenses sgaCurrentYTDDuration_NonConsolidatedMember233575000JPY
Other sgaPrior1YTDDuration_NonConsolidatedMember184384000JPY
Other sgaCurrentYTDDuration_NonConsolidatedMember164059000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember384886000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember397635000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-348844000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-359215000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember5000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember5000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember1986000JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember1279000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember197000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember114000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember2189000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember1399000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember418000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember388000JPY
Stock issuance cost prior noePrior1YTDDuration_NonConsolidatedMember5705000JPY
Stock issuance cost prior noeCurrentYTDDuration_NonConsolidatedMember8476000JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember6124000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember8864000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-352779000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-366680000JPY
Gain on reversal of subscription rights to shares eiPrior1YTDDuration_NonConsolidatedMember－JPY
Gain on reversal of subscription rights to shares eiCurrentYTDDuration_NonConsolidatedMember609000JPY
Gain on sales of subsidiaries and affiliates stocks eiPrior1YTDDuration_NonConsolidatedMember－JPY
Gain on sales of subsidiaries and affiliates stocks eiCurrentYTDDuration_NonConsolidatedMember15759000JPY
Extraordinary incomePrior1YTDDuration_NonConsolidatedMember－JPY
Extraordinary incomeCurrentYTDDuration_NonConsolidatedMember16369000JPY
Impairment loss elPrior1YTDDuration_NonConsolidatedMember2445000JPY
Impairment loss elCurrentYTDDuration_NonConsolidatedMember13172000JPY
Extraordinary lossPrior1YTDDuration_NonConsolidatedMember2445000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-06-30pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-06-30pass